The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Herpes zoster: A Review of Clinical Manifestations and Management
Open accessAbstract
The Varicella-zoster virus (VZV) or human herpes virus 3 is a neurotropic human alpha herpes virus responsible for chickenpox/varicella and shingles/Herpes zoster (HZ). This review will focus on HZ. Since HZ is secondary to varicella, its incidence increases with age. In children and youngsters, HZ is rare and associated to metabolic and neoplastic disorders. In adults, advanced age, distress, other infections (such as AIDS or COVID-19), and immunosuppression are the most common risk factors. HZ reactivation has recently been observed after COVID-19 vaccination. The disease shows different clinical stages of variable clinical manifestations. Some of the manifestations bear a higher risk of complications. Among the possible complications, postherpetic neuralgia, a chronic pain disease, is one of the most frequent. HZ vasculitis is associated with morbidity and mortality. Renal and gastrointestinal complications have been reported. The cornerstone of treatment is early intervention with acyclovir or brivudine. Second-line treatments are available. Pain management is essential. For (secondary) prophylaxis, currently two HZV vaccines are available for healthy older adults, a live attenuated VZV vaccine and a recombinant adjuvanted VZV glycoprotein E subunit vaccine. The latter allows vaccination also in severely immunosuppressed patients. This review focuses on manifestations of HZ and its management. Although several articles have been published on HZ, the literature continues to evolve, especially in regard to patients with comorbidities and immunocompromised patients. VZV reactivation has also emerged as an important point of discussion during the COVID-19 pandemic, especially after vaccination. The objective of this review is to discuss current updates related to clinical presentations, complications, and management of HZ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110475 · Cited by 1,027
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Beutner, K. R., Friedman, D. J., Forszpaniak, C., Andersen, P. L., & Wood, M. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1546 · Cited by 613
Molecular mechanisms of varicella zoster virus pathogenesis
Zerboni, L., Sen, N., Oliver, S. L., & Arvin, A. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3215 · Cited by 477
Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Marzano, A. V., Genovese, G., Fabbrocini, G., Pigatto, P., Monfrecola, G., Piraccini, B. M., Veraldi, S., Rubegni, P., Cusini, M., Caputo, V., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.044 · Cited by 386
Herpes zoster: Epidemiology, natural history, and common complications
Weinberg, J. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.046 · Cited by 278
A systematic literature review of herpes zoster incidence worldwide
van Oorschot, D., Vroling, H., Bunge, E., Diaz-Decaro, J., Curran, D., & Yawn, B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1847582 · Cited by 249
Bennett, J. L. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000768 · Cited by 209
Harbecke, R., Cohen, J. I., & Oxman, M. N. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab387 · Cited by 197
Oral nonsteroidal anti-inflammatory drugs for neuropathic pain
Moore, A., Chi, C., Wiffen, P. J., Derry, S., & Rice, A. S. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010902.pub2 · Cited by 145
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure
Izurieta, H. S., Wu, X., Forshee, R. A., Lu, Y., Sung, H.-M., Agger, P. E., Chillarige, Y., Link‐Gelles, R., Lufkin, B., Wernecke, M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab125 · Cited by 137
Triantafyllidis, K. K., Giannos, P., Tariq-Mian, I., Kyrtsonis, G., & Kechagias, K. S. (2021) · Vaccines · doi:10.3390/vaccines9091013 · Cited by 126
Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis
Nagel, M. A., Jones, D., & Wyborny, A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.03.014 · Cited by 124
Herpes zoster in Germany: Quantifying the burden of disease
Ultsch, B., Siedler, A., Rieck, T., Reinhold, T., Krause, G., & Wichmann, O. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-173 · Cited by 122
Herlin, L. K., Hansen, K. S., Bodilsen, J., Larsen, L., Brandt, C., Andersen, C. Ø., Hansen, B. R., Lüttichau, H. R., Helweg-Larsen, J., Wiese, L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa185 · Cited by 96
Sun, Y.-W., Kim, E., Kong, C. L., Arnold, B., Porco, T. C., & Acharya, N. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab121 · Cited by 87
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
Shiraki, K., Yasumoto, S., Toyama, N., & Fukuda, H. (2021) · Viruses · doi:10.3390/v13081547 · Cited by 87
Winthrop, K. L., Nash, P. T., Yamaoka, K., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220822 · Cited by 87
Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
Bardach, A., Palermo, C., Alconada, T., Sandoval, M., Balan, D. J., Guevara, J. N., Gomez, J. A., & Ciapponi, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255877 · Cited by 80
Herpes zoster risk after 21 specific cancers: population-based case–control study
Hansson, E., Forbes, H. J., Langan, S., Smeeth, L. L., & Bhaskaran, K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.124 · Cited by 79
Tsau, P.-W., Liao, M., Hsu, J.-L., Hsu, H., Peng, C.-H., Lin, Y., Kuo, H., & Ro, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040946 · Cited by 65
Huang, C., Lee, C., Sung, H.-Y., Liu, S., Liang, P.-C., & Tsai, M.-C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab675 · Cited by 64
A narrative review and clinical anatomy of herpes zoster infection following COVID ‐19 vaccination
Iwanaga, J., Fukuoka, H., Fukuoka, N., Yutori, H., Ibaragi, S., & Tubbs, R. S. (2021) · Clinical Anatomy · doi:10.1002/ca.23790 · Cited by 58
Ogilvie Syndrome and Herpes Zoster: Case Report and Review of the Literature
Edelman, D. A., Antaki, F., Basson, M. D., Salwen, W. A., Gruber, S. A., & Losanoff, J. E. (2009) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2009.02.010 · Cited by 53
Current In Vivo Models of Varicella-Zoster Virus Neurotropism
Mahalingam, R., Gershon, A. A., Gershon, M. D., Cohen, J. I., Arvin, A. M., Zerboni, L., Zhu, H., Gray, W. L., Messaoudi, I., & Traina‐Dorge, V. (2019) · Viruses · doi:10.3390/v11060502 · Cited by 52
Herpes Zoster: A Brief Definitive Review
Cohen, E. J., & Jeng, B. H. (2021) · Cornea · doi:10.1097/ico.0000000000002754 · Cited by 48
Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis
England, B. R., Mikuls, T. R., Xie, F., Yang, S., Chen, L., & Curtis, J. R. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40236 · Cited by 47
Curtis, J. R., Cofield, S. S., Bridges, S. L., Bassler, J. R., Deodhar, A. A., Ford, T. L., Huffstutter, J. E., Jankeel, A., Kivitz, A., Kamal, S., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6928 · Cited by 43
Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus
Kattah, J. C., & Kennerdell, J. S. (1978) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)77734-7 · Cited by 42
Herpes zoster ophthalmicus in COVID‐19 patients
Nofal, A., Fawzy, M. M., Deen, S. M. S. E., & El‐Hawary, E. E. (2020) · International Journal of Dermatology · doi:10.1111/ijd.15240 · Cited by 42
Vessel wall MR imaging of central nervous system vasculitis: a systematic review
Arnett, N., Pavlou, A., Burke, M. P., Cucchiara, B. L., Rhee, R. L., & Song, J. W. (2021) · Neuroradiology · doi:10.1007/s00234-021-02724-9 · Cited by 40
Kim, J., Kim, M. K., Choi, G. J., Shin, H. Y., Kim, B. G., & Kang, H. (2021) · The Korean journal of pain · doi:10.3344/kjp.2021.34.4.509 · Cited by 39
Herpes zoster as a marker of occult cancer: A systematic review and meta-analysis
Schmidt, S. A. J., Mor, A., Schønheyder, H. C., Sørensen, H. T., Dekkers, O. M., & Cronin-Fenton, D. P. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.11.005 · Cited by 36
Brunnemann, A.-K., Bohn-Wippert, K., Zell, R., Henke, A., Walther, M., Braum, O., Maschkowitz, G., Fickenscher, H., Sauerbrei, A., & Krumbholz, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05115-14 · Cited by 34
Experimental Drugs for Neuropathic Pain
Sałat, K., Gryzło, B., & Kulig, K. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180510151241 · Cited by 33
Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14437 · Cited by 32
A Review of the Clinical and Therapeutic Implications of Neuropathic Pain
Balzani, E., Fanelli, A., Malafoglia, V., Tenti, M., Ilari, S., Corraro, A., Muscoli, C., & Raffaeli, W. (2021) · Biomedicines · doi:10.3390/biomedicines9091239 · Cited by 30
Risk of recurrent herpes zoster in a population-based cohort study of older adults
Qian, J., Macartney, K. K., Heywood, A. E., Sheridan, S. L., & Liu, B. C. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.1013 · Cited by 29
Herpes Zoster and Subsequent Risk of Cancer: A Population-Based Study
Chiu, H., Chen, B., & Yang, C. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120155 · Cited by 26
Tang, Y. R., Ren, C., Wang, M., Dai, G., Xiao, Y., Wang, S., Han, F., & Chen, G. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147608 · Cited by 26
Burgard, B., Smola, S., VOGT, T. M., & Müller, F. M. (2018) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000001134 · Cited by 24
Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons
Rajbhandari, L., Shukla, P., Jagdish, B., Mandalla, A., Li, Q., Ali, M. A., Lee, H.-J., Lee, G., Sadaoka, T., Cohen, J. I., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01227-21 · Cited by 24
Dagnew, A. F., Klein, N. P., Hervé, C., Kalema, G., Paolo, E. D., Peterson, J., Salaun, B., & Schuind, A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa083 · Cited by 23
Puma, D. D. L., Marcocci, M. E., Lazzarino, G., Chiara, G. D., Tavazzi, B., Palamara, A. T., Piacentini, R., & Grassi, C. (2020) · Glia · doi:10.1002/glia.23895 · Cited by 22
Lee, C., Jiang, N., Tang, H., Ye, C., Yuan, Y., & Curran, D. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1932216 · Cited by 20
Communicability of varicella before rash onset: a literature review
Marin, M., Leung, J. W. T., Lopez, A. S., Shepersky, L., Schmid, D. S., & Gershon, A. A. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821001102 · Cited by 16
Wu, Y., Wang, C., Yu, L., Qian, W. P., Xing, X., Zhang, M., & Yan, M. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00510-y · Cited by 14
Gupta, S., Arasaratnam, R. J., Solow, E. B., & Bajaj, P. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001790 · Cited by 13
Zhou, J., Sun, W., Liu, Y., Yang, S., Wu, S., Wang, S., Xiong, D., Ho, I. H., Zhang, L., Chan, M. T. V., et al. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00303-7 · Cited by 12
Immunocompromised Districts of Skin: A Case Series and a Literature Review
Vojvodić, A., Tirant, M., Nardo, V. D., Lotti, T., & Wollina, U. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.680 · Cited by 11
Self-citationHwang‐Bo, J., Kim, B., Park, D. W., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00565-z · Cited by 6
Crouch, A., Le, M. A., Rogers, C. C., Shao, S., & Kotton, C. N. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13711 · Cited by 4
Metadata
- Authors
- Patil, A., Goldust, M., & Wollina, U.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2022-01-19
- Volume
- 14
- Issue
- 2
- Pages
- 192
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W4205658817
- Cited by
- 454
- References
- 53
- FWCI
- 55.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.